Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 12 of 16
Atomoxetine for Freezing of Gait in Parkinson's Disease
NCT03651856
Preventing Health Disparities During Pregnancy Through Vitamin D Supplementation
NCT01932788
Ketamine in Chronic Kid's (KiCK) Pain
NCT01755169
Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
NCT01816555
A Prospective Study Evaluating the Use of Intraoperative Stroke Volume Variation Via the FloTrac Device to Guide Fluid and Vasopressor Management in Head and Neck Free Flaps
NCT02186938
Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD
NCT01751035
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
NCT01738191
Effects of Transcranial Direct Current Stimulation on Pain Perception
NCT01860950
Oxytocin in Cocaine Dependence
NCT01573273
Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells
NCT01783431
A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma
NCT01593748
Vilazodone Treatment for Marijuana Dependence
NCT01574183
Varenicline for Adolescent Smoking Cessation
NCT01509547
Randomized Trial of Provider-Assisted Versus Patient-Initiated Enrollment in the Bedsider.Org Online Contraceptive Reminder Tool
NCT01990001
A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma
NCT01677962
Social Determinants of Health in Diabetes Outcomes
NCT01749345
Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
NCT01604590
Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma
NCT01677988
Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas
NCT01783054
Psychological First Aid for Victims of Crime
NCT01934348
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass
NCT01579513
Weight Loss Study for People With Type 2 Diabetes
NCT01601574
Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures
NCT01580709
Treatment Seeking Study
NCT05077514
Dose Response of Ketorolac in Knee Arthroscopy
NCT02181426
Maternal Epidural Steroids and Hyperthemia
NCT02212210
The Influence of Trust in the Health Care System on Postpartum Contraceptive Choice
NCT02213874
A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco
NCT01509586
Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
NCT01509404
Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2
NCT01363167
Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy
NCT02726113
Intestinal Function in Neonates With Complex Congenital Heart Disease
NCT01475357
Adherence Enhancement for Renal Transplant Patients
NCT01859273
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
NCT01509599
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
NCT01410981
Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals
NCT01963091
Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
NCT01333072
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
NCT02167464
Vitamin D to Improve Endothelial Function in SLE
NCT01911169
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
NCT01335204
Intrapartum Study of Sterile and Clean Gloves
NCT01852188
Cisplatin and Pemetrexed With Radiation Followed by Lobectomy
NCT01373463
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
NCT01338506
Family-Based Treatment for Parental Substance Abuse and Child Maltreatment
NCT01656837
Effect of Oxytocin on Stress in Marijuana Users
NCT01335789
Aripiprazole Effects on Alcohol Drinking and Craving
NCT01292057
Stress-induced Drinking in Emerging Adults: the Role of Trauma History
NCT01363180
Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures
NCT01221311
Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia
NCT01643798
Real-Time fMRI Feedback Effects on Pain Perception
NCT01588197
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.